European Multinational Registry on Prevention of Thromboembolic Events in Atrial Fibrillatio

Completed

• Conditions: MedDRA - 10003658 Atrial Fibrillation; I48.19

• Registration Number: DRKS00003343
• Lead Sponsor: Daiichi Sankyo Europe GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-12-14
• Study Completion: 2014-01-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 7228

Inclusion Criteria

Minimum age 18 years / Written informed consent for participation in the registry / History of Atrial Fibrillation documented by electrical tracing (ECG, Holter, pacemaker, implantable cardioverter defibrillator) within the prior 12 months

Exclusion Criteria

None

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Collection of data of subjects with atrial fibrillation regarding their medical history, their concomitant diseases and their treatment with a focus on the prevention of thromboembolic events.

Secondary Outcome Measures

Name	Time	Method
ot applicable